July 12 (Reuters) - (All figures in Swedish Crowns)
* Swedish Orphan Biovitrum AB (publ) SOBIV.ST reports
its second
quarter results on July 16.
* Year to date, Swedish Orphan Biovitrum AB (publ) shares
are up
4.64%.
* Below is a table of quarterly and annual analyst estimates
for
results based on LSEG data.
Qtr. to No. of Mean Actual-Qtr YoY Change
June 2024 analysts Estimate to June %
2023
Revenue 7 5.07 4.87 4.0
billion billion
Pre-tax 4 317.75 275.00 15.5
profit million million
EBIT 4 549.93 413.00 33.2
million million
Year to December No. of Mean Estimate
2024 Analysts
Revenue 11 24.51 billion
Pre-tax profit 8 4.17 billion
EPS 7 9.40
EBITDA 11 8.96 billion
EBIT 10 5.33 billion
Net Profit 8 3.41 billion
Dividend 8 0.00
Net Debt 6 14.08 billion
Swedish Orphan Biovitrum AB (publ) belongs to the OMX
Stockholm_PI.
Please note that consensus estimates may be updated between
publication of the poll and the report.
This summary was auto generated on July 12 at 06:02.
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))